CDCA3 and non-small cell lung carcinoma: With the continuous development and progress of clinical molecular biology, it has been found that cell division cycle-associated protein 3 (CDCA3) is abnormally highly expressed in non-small-cell lung cancer, gastric cancer, bladder cancer, leukemia, colon cancer, and breast cancer [16–21].